IPO registrations (S-1, F-1) · Registrants
Accelerate Diagnostics, Inc
- SEC CIK
- 727207 · filings on EDGAR ↗
- Former names
- ACCELR8 TECHNOLOGY CORP (1995–2012)
- Registration
- Form S-1, first filed 2023-12-13, last 2024-01-18; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2024-01-23; declared effective 2024-01-19
- Industry (SIC)
- Laboratory Analytical Instruments 3826
- Incorporated in
- DE
- Business address
- 3950 S. COUNTRY CLUB ROAD #470, BUILDING 3-307, Tucson, AZ 85714
- EIN
- 84-1072256
- EDGAR entity type
- operating
- Insiders and CEO pay
- Accelerate Diagnostics, Inc on the corporate pages
Offering terms
- Final price
- $1.73 per share (424B1 filed 2024-01-23)
- Shares sold
- 5,515,767
- Gross proceeds
- $9,542,276 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AXDX
- Lead underwriters
- William Blair
- Syndicate
- Craig-Hallum; September 30, Year Ended December 31 (2,023); Gross profit (loss) (1,917); As of December 31 (2,023)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Accelerate Diagnostics INC Fuzzy (name and state)
- Form 5500 plan sponsor: ACCELERATE DIAGNOSTICS, INC. EXACT (EIN (EXACT))
- Federal award recipient: ACCELERATE DIAGNOSTICS, INC Fuzzy (name and state)
- Form D issuer: Accelerate Diagnostics, Inc EXACT (CIK (EXACT))
- Lobbying client: ACCELERATE DIAGNOSTICS, INC. Fuzzy (name and state)
- SEC filer: Accelerate Diagnostics, Inc EXACT (CIK (EXACT))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2023-12-13 | S-1 | S-1 (registration) | Accelerate Diagnostics, Inc | 0001104659-23-125787 ↗ |
| 2024-01-16 | S-1/A | S-1/A (amendment) | Accelerate Diagnostics, Inc | 0001104659-24-003888 ↗ |
| 2024-01-18 | S-1/A | S-1/A (amendment) | Accelerate Diagnostics, Inc | 0001104659-24-004669 ↗ |
| 2024-01-19 | EFFECT | EFFECT (declared effective) | Accelerate Diagnostics, Inc | 9999999995-24-000159 ↗ |
| 2024-01-23 | 424B1 | 424B1 (final prospectus) | Accelerate Diagnostics, Inc | 0001104659-24-005673 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-18 | S-1/A | registration statement | 4,500,000 | - | Nasdaq AXDX | 2 | primary document; shares headline, cover names 2 | document ↗ | ||
| 2024-01-23 | 424B1 | final prospectus | $1.73 | 5,515,767 | $9,542,276 | Nasdaq AXDX | 5 | primary document; price line, shares headline, proceeds computed, underwriting table 3, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| GEIMER THOMAS J | Director,Officer | CEO and CFO; CEO/CFO; Chief Executive Officer/CFO | 9 | 2007–2012 | |
| GERRETSON CHARLES E | Director | 8 | 2008–2012 | ||
| Kucera John D. | Director | 7 | 2009–2012 | ||
| Howson David | Officer | President | 4 | 2009–2012 | |
| PATIENCE JOHN | Director; Director,TenPercentOwner; TenPercentOwner | 37 | 2012–2024 | ||
| SCHULER JACK W | Director,TenPercentOwner | 191 | 2012–2024 | ||
| ABEJA VENTURES, LLC | TenPercentOwner | 3 | 2012–2013 | ||
| Mehren Lawrence | Director,Officer; Director,Officer,TenPercentOwner | CEO; PRESIDENT AND CEO | 13 | 2012–2019 | |
| Strobeck Matthew | Director | 27 | 2012–2024 | ||
| REICHLING STEVEN | Officer | CFO; Chief Financial Officer; CHIEF FINANCIAL OFFICER | 32 | 2012–2023 | |
| FEINBERG LARRY N | TenPercentOwner | 25 | 2013–2016 | ||
| TEN BRINK FRANK JM | Director | 13 | 2013–2023 | ||
| MILLER MARK C | Director | 16 | 2013–2023 | ||
| Bantock Pete | Officer | CHIEF COMMERCIAL OFFICER; See Remarks | 5 | 2013–2017 | |
| Martin Joan | Officer | EXECUTIVE VP AND HEAD OF EMEA | 1 | 2017 | |
| Price Ron | Officer | Head of Commercial Operations; See Remarks; SVP & HEAD OF COM OPS AMERICAS | 10 | 2017–2022 | |
| Brown Thomas D | Director | 13 | 2017–2023 | ||
| Watts Charles M | Director | 8 | 2017–2023 | ||
| HUMPHRIES ROMNEY | Officer | Chief Scientific Officer; CHIEF SCIENTIFIC OFFICER | 3 | 2019–2020 | |
| Phillips Jack | Director,Officer; Officer | Chief Executive Officer; CHIEF OPERATING OFFICER; PRESIDENT AND CEO | 45 | 2019–2025 | |
| DIGGELMANN ROLAND D | Director | 3 | 2019–2020 | ||
| FRANCESCONI LOUISE | Director | 12 | 2019–2024 | ||
| SAFWAT NEDAL | Officer | Chief Strategy Officer | 2 | 2020 | |
| MASSARANY HANY | Director | 12 | 2021–2024 | ||
| BURRIS WAYNE | Director | 7 | 2022–2024 | ||
| Mertz Larry Michael | Officer | Chief Technology Officer | 13 | 2022–2025 | |
| Patience David | Officer | Chief Financial Officer | 20 | 2023–2025 | |
| Black Mark S. | Director | 3 | 2023–2024 | ||
| Ogilvie Marran H. | Director | 3 | 2023–2024 | ||
| Regan Jennifer | Director | 4 | 2023–2024 | ||
| Shalhoub Paul Vincent | Director | 1 | 2025 | ||
| NATHAN GILBERT E | Director | 1 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2022-04-07 | Accelerate Diagnostics, Inc | Biotechnology | $4,000,000 | $4,000,000 | 3 | 1 |
| 2021-09-29 | Accelerate Diagnostics, Inc | Biotechnology | $30,450,000 | $30,450,000 | 3 | 1 |
| 2021-03-01 | Accelerate Diagnostics, Inc | Biotechnology | $1,550,000 | $1,550,000 | 5 | 2 |
| 2019-08-28 | Accelerate Diagnostics, Inc | Biotechnology | $999,992 | $999,992 | 1 | 1 |
| 2014-06-04 | Accelerate Diagnostics, Inc | Biotechnology | $19,499,609 | $19,499,609 | 4 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Accelerate Diagnostics INC | AZ | State business registries | name and state |
| Federal award recipient | ACCELERATE DIAGNOSTICS, INC | AZ | Federal spending (USAspending) | name and state |
| Form D issuer | Accelerate Diagnostics, Inc | AZ | Form D private offerings | CIK (EXACT) |
| Lobbying client | ACCELERATE DIAGNOSTICS, INC. | AZ | Federal lobbying (LDA) | name and state |
| Paying company | Accelerate Diagnostics Inc. | AZ | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Accelerate Diagnostics, Inc. | AZ | Patents (USPTO) | name and state |
| SEC filer | Accelerate Diagnostics, Inc | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Accelerate Diagnostics, Inc. | AZ | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ACCELERATE DIAGNOSTICS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Laboratory Analytical Instruments, AZ first:
- HTG MOLECULAR DIAGNOSTICS, INC AZ
- NGEN, INC. CA
- CEPHEID CA
- LJL BIOSYSTEMS INC CA
- AGILENT TECHNOLOGIES, INC. CA
- ILLUMINA, INC. CA
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CA
- QPC Lasers CA
- WaferGen Bio-systems, Inc. CA
- PROTEINSIMPLE CA
In other datasets, the same topic (Technology) in AZ:
- Form D issuer: 1WorldNow LLC (Form D private offerings)
- Lobbying client: 3001 INC (Federal lobbying (LDA))
Interests: Laboratory Analytical Instruments · Technology